Roundtable: The benefits of liquid biopsy for Pancreatic Cancer Patient Management
For more information please contact us directly at Pancreatic Cancer Europe.
Putting pancreatic cancer on the map – what we have and what we need
On Wednesday, October 10th of 2018, the Digestive Health Group of the European Parliament organised, together with Pancreatic Cancer Europe (PCE) and United European Gastroenterology (UEG), the event “Putting pancreatic cancer on the… …Read More »Putting pancreatic cancer on the map – what we have and what we need
A Platform for Pancreatic Cancer – Pan European Network
Pancreatic Cancer Europe has collaborated with Pan European Networks: Health which provided a very nice portrait of the Platform, our identity and our actions to tackle the disease. Our Board Member, Dr Nuria… …Read More »A Platform for Pancreatic Cancer – Pan European Network
DIPLOMA trial, a clinical trial on distal pancreatectomy, minimally invasive or open, for malignancy
The new PCE member Dutch Pancreatic Cancer is a member of the European Consortium of Minimally Invasive Pancreatic Surgery (E-MIPS). E-MIPS has recently organized the DIPLOMA trial, which is coordinated by the AMC… …Read More »DIPLOMA trial, a clinical trial on distal pancreatectomy, minimally invasive or open, for malignancy
Towards an early screening tool for pancreatic cancer?
Pancreatic cancer has one of the worst prognoses, with a five-year survival rate of 9 percent, because of the lack of telltale symptoms or non-invasive screening tools to catch a tumor before it… …Read More »Towards an early screening tool for pancreatic cancer?
ESMO GI 2017
Pancreatic Cancer Europe is proud to endorse ESMO World Congress on Gastrointestinal Cancer 2017. The ESMO World Congress on Gastrointestinal Cancer is the premier global event in the field – encompassing malignancies affecting… …Read More »ESMO GI 2017
Multi-stakeholder brainstorming meeting on pancreatic cancer research
“On Wednesday 12th April 2017, EUPancreas (COST Action) and Pancreatic Cancer Europe gathered key pancreatic cancer research experts, clinicians, private domain representatives, health policy makers, and patient advocates during a meeting in Brussels.… …Read More »Multi-stakeholder brainstorming meeting on pancreatic cancer research
A new sponsor for PCE!
We are very delighted to announce you that Pancreatic Cancer Europe has a new sponsor! Indeed, Mylan has joined us into our effort to raise awareness about pancreatic cancer. Three years after its… …Read More »A new sponsor for PCE!
“The silent cancer” – Matthias Löhr’s interview for Horizon 2020
Pancreatic cancer will this year become the third biggest cancer killer in the EU, yet awareness of the disease remains worryingly low. PCE Board Member, Matthias Löhr, on behalf of United European Gastroenterology… …Read More »“The silent cancer” – Matthias Löhr’s interview for Horizon 2020
Pancreatic Cancer Europe members gather in Brussels for the General Assembly meeting of the association
On 15 November, the members of Pancreatic Cancer Europe gathered in Brussels for their General Assembly meeting. At this occasion, members reviewed the 2016 action plan of PCE, and discussed and agreed on… …Read More »Pancreatic Cancer Europe members gather in Brussels for the General Assembly meeting of the association
Pancreatic Cancer awareness event in the European Parliament
To mark World Pancreatic Cancer Day 2016, Pancreatic Cancer Europe organised an awareness event in the European Parliament, hosted by Mr Pavel Poc MEP, under the auspices of the Slovak Presidency in the… …Read More »Pancreatic Cancer awareness event in the European Parliament
World Pancreatic Cancer Day 2016
At the occasion of World Pancreatic Cancer Day 2016, Pancreatic Cancer Europe is organising jointly with Mr Pavel Poc MEP an awareness event in the European Parliament, held under the auspices of the… …Read More »World Pancreatic Cancer Day 2016
Pancreatic cancer will this year become the third biggest cancer killer in the EU
At the occasion of the 49th meeting of the European Pancreatic Club (EPC), the founding members of Pancreatic Cancer Europe*, newly established as a non-profit association, gathered in Liverpool on 6 July. This meeting marked a new milestone in the life of Pancreatic Cancer Europe, and its continued work to improve the prioritisation of pancreatic ...Read More »Pancreatic cancer will this year become the third biggest cancer killer in the EU
Two-drug combination improves survival for operable pancreatic cancer
The results of a large pan-European study by the European Study Group for Pancreatic Cancer (ESPAC) involving 732 patients has shown that the combination of gemcitabine plus capecitabine adjuvant therapy (following successful resection of the tumour) significantly improved survival. Presented at the American Society for Clinical Oncology1 in Chicago this week, the lead researchers from ...Read More »Two-drug combination improves survival for operable pancreatic cancer
Have we now found a way for immunotherapy to work in pancreatic cancer too?
We have seen a lot in the press recently about the advances in immunotherapy for many cancers and, in the case of melanoma, with extraordinary results. We’ve not as yet seen this happen for pancreatic cancer which, so far, has proven difficult to treat with either conventional chemotherapy and/or novel immunotherapy. Some trials of immunotherapy ...Read More »Have we now found a way for immunotherapy to work in pancreatic cancer too?
Launch of the Pancreatic Cancer Overall Survival Registry EUROPE (PancreOS)
Pancreatic cancer will become the 2nd leading cause of cancer-related death by the year 2030. There are different standards, therapies and settings in the European countries. Furthermore, there is no target-oriented treatment for patients with pancreatic cancer. “We treat all patients with Pancreatic cancer alike”, Professor Alfredo Carrato said, “but there are different groups and ...Read More »Launch of the Pancreatic Cancer Overall Survival Registry EUROPE (PancreOS)
World Pancreatic Cancer Day 2015
On the occasion of the 2nd World Pancreatic Cancer Day, the European Multi-Stakeholder Platform on Pancreatic Cancer held its third face-to-face meeting in the European Parliament, in Brussels, on November 10th.
- « Previous
- 1
- 2